Navigation Links
Interface Biologics' Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
Date:9/16/2008

TORONTO, Sept. 16 /PRNewswire/ - In a head to head comparison of Interface Biologics Inc. (IBI) Endexo Anti-thrombic additives versus commercially available heparin coated catheters, both products achieved significant reductions (88%) in thrombus versus the polyurethane (Carbothane(TM)) control (data on file).

"Due to the recent contamination, subsequent price increases, and safety issues for Heparin, catheter manufacturers are seeking alternative coatings for their products. Interface Biologics' Endexo(TM) anti-thrombic additives are non-drug polymers that have anti platelet properties. These polymers are compatible with a wide range of base polymers, and since they are an additive rather than a coating, afford ease of process manufacturing as well as provide both extra and intraluminal coverage, and are equivalent in thrombus reduction performance to commercially available coatings," stated Rich Sullivan, President and CEO of Interface Biologics.

The blood loop study was performed at the Medical Device Evaluation Center (MDEC) in Salt Lake City Utah. "Catheters with effective Endexo additives showed a significant reduction in thrombus versus a standard polyurethane control, and were not statistically different in antithrombotic efficacy versus a commercially available heparin coated catheter," stated Sivaprasad Sukavaneshvar, Ph.D., VP of MDEC.

About Interface Biologics Inc.

Interface Biologics is a biomaterials company located in Toronto, Canada. The company develops and manufactures novel anti-thrombic and anti-infective polymers used in medical devices for cardiovascular and urological applications.


'/>"/>
SOURCE Interface Biologics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Velos to Develop Key System Interface for Clinical Research
2. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
3. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
4. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
5. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
6. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
7. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
8. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
9. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
10. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
11. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , LONDON , ... May 20, 2013 Arthroscopy ... Osteoarthritis and Preference for Minimally Invasive Procedures to Drive ... and market trends for the six arthroscopy device market ... arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy visualization ...
(Date:5/20/2013)... 20, 2013  Neuralstem, Inc. (NYSE MKT: CUR) today ... PhD, principal investigator, presented updated Phase I data from ... in the treatment of amyotrophic lateral sclerosis (ALS or ... neuro diabetes special medical symposium in Bucharest, ... "Recent Therapeutic Advances in Stem Cell Therapy," Dr. Feldman ...
(Date:5/20/2013)... With herbal medicines relied upon by consumers ... Pharmacopeial Convention (USP) will provide freely available public standards ... used in these products. Today, USP proposes the first ... Herbal Medicines Compendium ( HMC ) for comment ... . HMC will provide standards for ...
Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3
... LOS ANGELES, Oct. 24, 2011 NeuroSigma, Inc., a ... has signed a contract with the University of California, ... clinical trial to study the use of non-invasive, external ... Deficit Hyperactivity Disorder (ADHD).  NeuroSigma is the exclusive worldwide ...
... HealthWarehouse.com, Inc. (OTC: HEWA), a leading VIPPS-accredited ... begin providing prescription medications for WhiteGlove Health, Inc., ... excited to have a national partner to provide ... Robert Fabbio, co-founder and chief executive officer of ...
Cached Medicine Technology:NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD 2NeuroSigma Funds First-Ever Pediatric Clinical Trial to Study Non-Invasive External Trigeminal Nerve Stimulation for the Treatment of ADHD 3WhiteGlove Health Selects HealthWarehouse.com to Provide Prescription Medications to its Members Nationwide 2
(Date:5/21/2013)... The National Resident Matching Program NRMP® ... Board of Directors. Hal B. Jenson, M.D., M.B.A, ... Medicine, has been named President. Maria C. Savoia, ... California San Diego, is the President-Designate, and Glenn A. ... Center, is the Secretary-Treasurer. Kenneth B. Simons, M.D., ...
(Date:5/21/2013)... 2013 Joe Vitale, a positive thinking guru ... of the Fisker electric car. After a year and a ... car company went bankrupt, the bestselling author turned grumpy car ... "It's a gas guzzler's anthem," says Vitale, 59, who recorded ... Will Rise." , Owning this Fisker was a personal ...
(Date:5/21/2013)... Limited mobility affects people in ways that ... more difficult to walk around, but everyday tasks like getting ... variety of medical products made to assist those who need ... toilet seat. , Raised toilet seats keep users ... up or sit down. They come in a variety of ...
(Date:5/20/2013)... This week has been dedicated as National ... 19th-May 25th) is an awareness campaign designated to help prevent ... dog owners to properly train their pets, and educate children ... bite lawyers at Buckfire & Buckfire, P.C. represent victims ... The personal injury law firm is a large advocate of ...
(Date:5/20/2013)... 2013 Recent environmental concerns have ... green and sustainable inputs in packaging products. As ... to promote the use of sustainable materials, thereby ... Services industry . “Tax subsidies and operating cost ... industry analyst Deonta Smith. “For example, many packaging ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:Upset Fisker Owner Records Gas Guzzler Anthem 2Health News:JustHomeMedical.com Launches Raised Toilet Seats Category 2Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3
... ... Results, WALNUT CREEK, Calif., May 28 Longs Drug,Stores Corporation (NYSE: ... at its 2008 Annual Meeting of Stockholders., The Board of Directors ... of $0.14 per share payable July,10, 2008 to stockholders of record at ...
... Inc. (Nasdaq:,BLUD), a global leader in providing automated ... it expects to release its,fiscal 2009 guidance on ... regular,trading hours, and then host a conference call ... to discuss expectations for fiscal 2009. Investors are,invited ...
... by,Attorney General Michael B. Mukasey on the Justice Department,s ... good afternoon. I,m pleased to be here today to,highlight ... is doing to,fight health care fraud. I,d particularly like ... and everyone here for your hard,work., Our nation,s ...
... Caribbean People,International Collective Inc (CPIC) will host AIDS ... set for Sunday, June 8th 2008--Caribbean,American HIV/AIDS Awareness Day. ... 9:30 A.M. and then will kick off from the ... The 5 K Walk will,continue throughout much of Flatbush ...
... show positive impacts on safety, quality of care, clinician ... efficiency ... Dartmouth-Hitchcock,Medical Center and Masimo (Nasdaq: MASI ), the ... initial results of an ongoing clinical evaluation show,Masimo Patient ...
... effective drugs to slow progression of disease , , WEDNESDAY, ... a role in Alzheimer,s disease in two large families ... has been identified by U.S. researchers. , Identification of ... a new line of research that may help improve ...
Cached Medicine News:Health News:Longs Drug Stores Corporation Announced at Its Annual Meeting of Stockholders 2Health News:Immucor Schedules Fiscal 2009 Guidance Call 2Health News:Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Department's Efforts to Combat Healthcare Fraud Nationwide 2Health News:Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Department's Efforts to Combat Healthcare Fraud Nationwide 3Health News:Caribbean People International Collective Inc to Host 8th Annual AIDS WALK CARIBBEAN 2Health News:Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors 2Health News:Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors 3Health News:Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors 4Health News:Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors 5Health News:Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors 6Health News:Dartmouth-Hitchcock Medical Center Evaluation Findings Demonstrate Masimo Patient SafetyNet(TM) Delivers Improvements in Clinical Outcomes and Patient Safety on General Care Floors 7Health News:Study IDs Gene for Late-Onset Alzheimer's 2
The WaveMap provides immediate clinical decision making information with automatic calculation of pressure gradients and FFR measurements.,SmartWire Pressure Guide Wire - The intelligent choice in ...
... for vascular access. Hollow stylet ... wall puncture with two-part needle. ... visualized while maintaining thumb position ... the hub of the stylet. ...
Used for placement of .035 inch (0.89 mm) or .038 inch (0.97 mm) diameter wire guides into the vascular system when a small 24 gage needle stick is desired....
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Medicine Products: